Home » AstraZeneca to Acquire Chinese Generics Company
AstraZeneca to Acquire Chinese Generics Company
AstraZeneca has signed an agreement to acquire Guangdong BeiKang Pharmaceutical, a China-based generics manufacturing company.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
07May
-
14May
-
30May